adar poonawala
Jump to
9 Results Found
  • What ‘second wave’ means for investors in Indian pharma Apr 12, 2021 10:25 AM IST

    What ‘second wave’ means for investors in Indian pharma

    Multi-year opportunity awaits Indian vaccine manufacturers such as DRL, Gland Pharma, Aurobindo Pharma and Cadila Pharma

  • Will send Covishield to Canada in less than a month, says SII's Adar Poonawalla Feb 15, 2021 04:01 PM IST

    Will send Covishield to Canada in less than a month, says SII's Adar Poonawalla

    Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine. Prime Minister Narendra Modi on February 10 had assured his Canadian counterpart Justin Trudeau that India would do its best to facilitate supplies of COVID vaccines sought by Canada.

  • The vaccine controversy deals a big blow to India’s global profile Jan 07, 2021 08:59 AM IST

    The vaccine controversy deals a big blow to India’s global profile

    The unseemly hurry to hand out approvals without adequate data in at least one case has long term implications for the Indian vaccine industry’s reputation

  • How prepared is India for a COVID-19 vaccine? Nov 26, 2020 10:53 AM IST

    How prepared is India for a COVID-19 vaccine?

    As things stand, the COVID-19 vaccination programme will be an enormous national project. An acceleration of the timetable may turn out to be the biggest effort the Indian State has made in its history

  • Anand Mahindra's tweet on 'Big V' vaccine: Here's how Adar Poonawalla responded Aug 04, 2020 11:05 AM IST

    Anand Mahindra's tweet on 'Big V' vaccine: Here's how Adar Poonawalla responded

    In a tweet on August 2, Mahindra had joked about a vaccine called "Big V", a reference to the Amitabh Bachchan's popular nickname "Big B" and how all of India needs a dose of that.

  • Exclusive: Poonawalla family's Serum Institute looks to raise $1 billion for big-ticket COVID-19 vaccine project Jun 26, 2020 04:39 PM IST

    Exclusive: Poonawalla family's Serum Institute looks to raise $1 billion for big-ticket COVID-19 vaccine project

    Investment banks Goldman Sachs, Citi and Avendus Capital have been engaged as advisors for the process by the privately held vaccine manufacturer, say sources.

  • Interview - Serum Institute's Adar Poonawala plans new vaccines and an NBFC Jul 05, 2018 02:10 PM IST

    Interview - Serum Institute's Adar Poonawala plans new vaccines and an NBFC

    Adar Poonawala took over from his father Cyrus, to guide the fortunes of the group. In an exclusive interview, he spoke about some of the group’s initiatives.

  • Looking for bigger partnership with Cipla: Serum Institute Jan 21, 2017 02:51 PM IST

    Looking for bigger partnership with Cipla: Serum Institute

    Adar Poonawala, CEO of Serum Institute, believes that a bigger partnership with Cipla will create a big Indian conglomerate. However, he added that the Cipla promoters currently have no plans for a merger and acquisition.

  • Cipla-Serum merger unlikely in near future: Adar Poonawala Jan 07, 2016 08:52 PM IST

    Cipla-Serum merger unlikely in near future: Adar Poonawala

    Serum Institute CEO Adar Poonawala has told CNBC-TV18 that Cipla and Serum will not be merging anytime soon. Cipla and Serum Institute have joined hands to sell products jointly across various countries in the world.

Sections